Stock Update (NYSE:PFE): AstraZeneca trumpets solo strength in cancer drugs, snubbing Pfizer

[Reuters - UK Focus] – AstraZeneca touted an “industry-leading” line-up of hot new cancer drugs on Tuesday, aiming to show investors it has a strong independent future just days before takeover rules would . . . → Read More: Stock Update (NYSE:PFE): AstraZeneca trumpets solo strength in cancer drugs, snubbing Pfizer Similar Articles: Stock Update: Pfizer Inc (NYSE:PFE) – Pfizer and Breast Cancer Leaders Join Together to Increase Understanding and Dispel Myths about Metastatic Breast Cancer Company Update: Pfizer Inc (NYSE:PFE) – Pfizer Completes Acquisition Of InnoPharma Pfizer Inc (NYSE:PFE) – French biotech Cellectis surges as Pfizer signs cancer drug deal